Hanmi To Step Up Global Drug Development As Lilly Returns BTK Rights

 
• By Jung Won Shin
  
Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV - Image
Lilly Returns Rights To Hanmi's BTK Inhibitor
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia